Radboud universitair medisch centrum Stichting

• Research into existing medicines to reduce aging, pain, and inflammation in osteoarthritis. Not authorised
  2025-524885-12-00 Phase II 1 country BARICITINIB; COLCHICINE; DOLUTEGRAVIR; METFORMIN HYDROCHLORIDE
• Colchicine and Inflammation in Aortic Stenosis (CHIANTI) trial Pending
  2024-513486-39-00 Phase III 1 country COLCHICINE
• Unravelling the invisiBle infiltRating cOmponeNT Of glioblaStomA Using mRi USpio (BRONTOSAURUS) Pending
  2024-514013-34-00 Phase IV 1 country
• The effect of Oxygen sUppleTion on vascular resistance and FLOW: the OUTFLOW study Pending
  2024-516279-34-00 Phase IV 1 country OXYGEN
• Fast awakening from general anesthesia, an observational intervention study in healthy volunteers Pending
  2024-516415-24-03 Phase IV 1 country FLUMAZENIL; NALOXONE HYDROCHLORIDE; ROCURONIUM BROMIDE; SUFENTANIL CITRATE; SUGA…
• A phase 2 trial of capecitabine for recurrent and/or metastatic salivary duct carcinoma – CAESAR trial Pending
  2024-516956-16-01 Phase II/III 1 country
• Image-Verapamil SR in Adults with Type 1 Diabetes (Image-VER-A-T1D) Pending
  2024-518554-17-00 Phase II 2 countries
• Ultimate dePletion of autoReactive b cells using Obinutuzumab from sjÖgren's syndrome affected Tissues study- UPROOT study Pending
  2024-519884-16-00 Phase II 1 country OBINUTUZUMAB
• Imaging beta cells after gestational diabetes Pending
  2024-520392-27-00 Phase II 1 country
• Research into the effect of Obinutuzumab on the level of PLA2R antibodies in patients with membranous nephropathy. Pending
  2025-521139-35-01 Phase II 1 country OBINUTUZUMAB
• The NIMBUS study: A study on inhalation therapy with liposomal amphotericin B and its distribution in the lungs in chronic pulmonary fungal … Pending
  2025-521770-34-00 Phase I (Other) 1 country AMPHOTERICIN B
• Healing Diabetic Foot Ulcers with Semaglutide Pending
  2025-524738-24-00 Phase IV 1 country SEMAGLUTIDE
• A clinical study investigating modafinil for the treatment of severe fatigue in patients with inflammatory bowel disease (MODIFI-IBD trial) Pending
  2026-525163-41-00 Phase II/III 1 country MODAFINIL
• Insulin nasal spray to prevent delirium after cardiac surgery Recruiting
  2025-524680-21-00 Phase II/III 1 country INSULIN HUMAN; SODIUM CHLORIDE
• Click-cleavable imaging in HER2-positive cancers (CleavHER trial). Recruiting
  2025-520673-39-00 Phase I 1 country
• Pharmacologically modulating the noradrenergic arousal system to reduce freezing of gait in Parkinson’s disease: a multi-center and multi-mo… Recruiting
  2024-516756-18-00 Phase III 1 country ATOMOXETINE
• Anti-inflammatory drug to prevent complications in type 1 diabetes Recruiting
  2025-521397-34-00 Phase III/IV 1 country COLCHICINE
• ISEE-RCC study Recruiting
  2024-514181-39-00 Phase III 1 country GALLIUM (68GA) GOZETOTIDE; ZIRCONIUM (89ZR) GIRENTUXIMAB
• Shorter weaning from invasive ventilation with levosimendan: a randomized, double-blind, multicenter study in critically ill patients. Recruiting
  2024-518810-23-00 Phase IV 1 country LEVOSIMENDAN; PANTOTHENATE SODIUM, RIBOFLAVIN SODIUM PHOSPHATE, BIOTIN, CYANOCOB…
• Efficacy and safety of repeated Rituximab infusions in patients with Active Systemic SClerosis and background medication, a one year randomi… Recruiting
  2025-520483-17-01 Phase IV 1 country RITUXIMAB; SODIUM CHLORIDE
• Efficacy of Reduced Gadolinium Dose in Contrast-Enhanced Breast MRI Recruiting
  2024-518549-27-00 Phase III/IV 1 country GADOTERIC ACID
• Ravulizumab dose optimization Recruiting
  2024-519207-10-00 Phase IV 1 country RAVULIZUMAB
• The MIRAGE study. Use of radioactively labelled deferoxamine for a novel purpose: imaging pulmonary aspergillosis with PET/CT scans. Recruiting
  2023-509744-10-00 Phase II 1 country
• Efficacy and safety of minidosing lysergic acid diethylamide (LSD) for chronic cluster headache: a randomized placebo-controlled study Recruiting
  2024-520305-39-00 Phase II 1 country LYSERGIDE

Showing 1–24 of 49 trials